Answers are grounded in this paper and cite their sources.
Objectives Multiple sclerosis (MS) is increasingly recognised as a systemic immune-mediated disease extending beyond the central nervous system (CNS). Although intestinal dysbiosis has been implicated in MS pathogenesis, whether gut microbial metabolism and CNS inflammation are linked at disease onset remains unknown. Methods In this prospective single-centre study, patients were enrolled at their first demyelinating event. Stool samples were collected before corticosteroid and disease-modifying therapy. Fecal short-chain fatty acids (SCFAs) were quantified by gas chromatography and fecal calprotectin by enzyme-linked immunosorbent assay (ELISA), and their concentrations were analyzed in relation to routine CSF parameters. Results Seventeen patients were enrolled. CSF-IgM concentrations inversely correlated with faecal butyrate (r = −0.673, p = 0.003), valerate, isovalerate and isobutyrate (all p < 0.05), and with the relative butyrate proportion (r = −0.698, p = 0.002); the IgM index behaved similarly. CSF-IgM correlated with EDSS at month 18 (p = 0.030) and faecal butyrate with EDSS change from baseline (ΔEDSS; p = 0.019); butyrate/IgM ratio was also associated with disability in both analyses (p = 0.021 and p = 0.031). Discussion We show that reduced faecal SCFA levels are associated with early CSF inflammation and that both are associated with subsequent disability. These findings are compatible with a potential gut-CNS inflammatory axis at MS onset. A causal relationship has yet to be confirmed.
No takes yet. Share an insight, caveat, or question.
Kämpfer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: